JCI - Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

Brian J. Druker, Nicholas B. Lydon

Published in Volume 105, Issue 1

J Clin Invest. 2000; 105(1):3 doi:10.1172/JCI9083

Full text | PDF

Citation information

Citation in:
Citations:

2011
4

2010
11

2009
5

2008
8

2007
10

2006
12

2005
19

2004
14

2003
17

>>
(39)

Total
12

Title and authors	Publication	Year	.
Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease Rafael León, Antonio G. Garcia, José Marco-Contelles	Res Rev	2011	.
MicroRNAs 130a/b are regulated by BCR-ABL and downregulate expression of CCN3 in CML Sukanya Suresh, Lynn McCallum, Wanhua Lu, Noureddine Lazar, Bernard Perbal, Alexandra E. Irvine	J Cell Commun Signal	2011	.
Molecular mechanisms of drug resistance in tyrosine kinases cAbl and cKit Jonathan P. DiNitto, Joe C. Wu	CRC Critical Rev Biochem	2011	.
Single-Molecule Recognition of Biomolecular Interaction <i>via</i> Kelvin Probe Force Microscopy Jinsung Park, Jaemoon Yang, Gyudo Lee, Chang Young Lee, Sungsoo Na, Sang Woo Lee, Seungjoo Haam, Yong-Min Huh, Dae Sung Yoon, Kilho Eom	ACS Na	2011	.
Sustained Superior Long-Term Outcomes and Cytogenetic Responses with Imatinib Mesylate in Chronic Phase Chronic Myeloid Leukaemia: Report from a Developing Country Z. Aziz, J. Iqbal, K. Bano, M. Faisal, M. Akram	Japan J Clin Oncol	2010	.
Understanding Life as Molecules: Reductionism Versus Vitalism Marc Fontecave	Angew Chem Int E	2010	.
Keykavous Parang, Gongqin Sun	Pharmaceutical Sciences Encyclopedia	2010	.
Das Leben molekular verstehen: Reduktionismus gegen Vitalismus Marc Fontecave	angew chemie	2010	.
Chronic Myeloid Leukemia: A Historical Perspective John M. Goldman	SEMIN HEMATOL	2010	.
Libraries of 2β-(N-substituted piperazino)-5α-androstane-3α, 17β-diols: chemical synthesis and cytotoxic effects on human leukemia HL-60 cells and on normal lymphocytes Jenny Roy, René Maltais, Hajer Jegham, Donald Poirier	Mol Divers	2010	.
ROS receptor tyrosine kinase: a new potential target for anticancer drugs Ibrahim Mustafa El-Deeb, Kyung Ho Yoo, So Ha Lee	Res Rev	2010	.
Seven-year response to imatinib as initial treatment versus re-treatment in Chinese patients with chronic myelogenous leukemia in the chronic phase Hao Jiang, Shan-Shan Chen, Bin Jiang, Qian Jiang, Ya-Zhen Qin, Yue-Yun Lai, Xiao-Jun Huang	Ann Hematol	2010	.
Bioconjugates to specifically render inhibitors water-soluble Anna K. H. Hirsch, François Diederich, Markus Antonietti, Hans G. Börner	Soft Matt	2010	.
The expression of syndecan-1 is related to the risk of endometrial hyperplasia progressing to endometrial carcinoma Hyunjin Kim, Dong Soon Choi, Suk-Joon Chang, Jae Ho Han, Churl K. Min, Ki-Hong Chang, Hee-Sug Ryu	J Gynecol Oncol	2010	.
Stability Analysis of a Simplified Yet Complete Model for Chronic Myelogenous Leukemia Marie Doumic-Jauffret, Peter S. Kim, Benoît Perthame	Bull Math Biol	2010	.
Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice João Carlos da Silva Bizario, Daniel Giuliano Cerri, Lilian Cataldi Rodrigues, Gislane L.V. Oliveira, Auro Nomizo, Daniela Dover de Araujo, Paula Sakemi Fukuhara, Juliana Caldas Ribeiro, Fabíola Attié de Castro, Maria Cristina Ramos Costa	J Neuroimmunol	2009	.
Chemical genetic screening in the zebrafish embryo Charles K Kaufman, Richard M White, Leonard Zon	Nat Protoc	2009	.
Strategies to enhance rituximab anti-tumor activity in the treatment of CD20-positive B-cell neoplasms Wasif Riaz, Francisco J. Hernandez-Ilizaliturri, Myron S. Czuczman	IR	2009	.
Attacking cancer at its foundation Nicholas Lydon	Nat Med	2009	.
Zebrafish modelling of leukaemias Elspeth Payne, Thomas Look	BR J HAEM	2009	.

« Previous 1 2 3 4 5 6 7 Next »